Petros Grivas
@PGrivasMDPhD
Followers
18K
Following
47K
Media
1K
Statuses
22K
Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
Seattle, WA
Joined July 2015
So fun to chat with @DrRanaMcKay @CaPsurvivorship & Neal Shore on #prostatecancer updates & clinical implications! @OncLive link below:. @OncBrothers @EAntonarakis @neerajaiims @TiansterZhang @montypal @fredhutch @nicoleflemingmd @PCFnews @HsiehLab.
0
3
21
Thanks for sharing @PavlosMsaouel we appreciate you & your team’s important work in the oncology & biostatistics fields!.
1/5 How reproducible are phase III oncology trials?.📊 With @AlexSherryMD @ErikVanZwet @ebludmir et al. We analyzed 632 RCTs (~496,000 pts). The data offer both reassurance and caution for clinicians and researchers. 👇#MsaouelLab
1
0
9
RT @medoncodoc: Molecular and therapeutic landscape of non-clear cell renal carcinoma . @DrChoueiri @urotoday @DrR….
0
23
0
RT @PavlosMsaouel: 2/5 Back in 2021 we published evidence that high-intensity exercise may be the first modifiable RMC risk factor—SCT athl….
0
2
0
RT @PavlosMsaouel: 1/5 #RenalMedullaryCarcinoma (RMC) is a lethal #KidneyCancer in young people with #SickleCellTrait (SCT). Our new prospe….
0
21
0
RT @Ben_Bowers__: Our new research findings - Healthcare systems need to factor in senior clinical support & workforce capacity to enable c….
0
19
0
RT @KalChitturi: 📢 Excited to share our latest publication in @CRMjournal!. “DAPT Selection and Duration Before and After PCI: Beyond the G….
0
5
0
RT @oncodaily: Petros Grivas is Receiving 2025 Young Investigator Award.@PGrivasMDPhD @CParkMD @fredhutch . #Cance….
0
2
0
RT @siadaneshmand: Should #radicalcystectomy ever be considered for consolidate therapy post EV/P?@PGrivasMDPhD @sh….
0
28
0
RT @oncodaily: @CParkMD @PGrivasMDPhD We would like to inform you that your post has been published on Thank you f….
0
1
0
RT @DrYukselUrun: Nivo + Ipi combo shows 54% ORR in gynecologic clear cell cancers (CCOC/CCEC).All responses still ongoing. 6-month PFS: 58….
0
29
0
RT @DrYukselUrun: @US_FDA approves durvalumab for perioperative immunotherapy for patients with muscle-invasive bladder cancer.In a prespe….
0
7
0
RT @nataliagandur: 🌟Challenges in Defining Clinical CR to Systemic Therapy in MIBC🌟.@EORTC #STARBURST project.🖋️ Alexandra Masson-Lecomte @….
0
17
0
RT @nataliagandur: 💫🌟Personalizing Radical Cystectomy in the EVP Era.By @siadaneshmand @USC_Urology @OncoAlert.✨ A brilliant, forward-look….
0
12
0
RT @OncBrothers: GU Malignancy Highlights from #ASCO25 w/ @TiansterZhang! . ✅ #Keynote564.✅ #AMPLITUDE .✅ #ARANOTE .✅ #NIAGARA . Full Disc….
0
7
0